John C. W. Lim

717 total citations
20 papers, 236 citations indexed

About

John C. W. Lim is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, John C. W. Lim has authored 20 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 8 papers in Public Health, Environmental and Occupational Health and 3 papers in Infectious Diseases. Recurrent topics in John C. W. Lim's work include Pharmaceutical Economics and Policy (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Biomedical Ethics and Regulation (3 papers). John C. W. Lim is often cited by papers focused on Pharmaceutical Economics and Policy (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Biomedical Ethics and Regulation (3 papers). John C. W. Lim collaborates with scholars based in Singapore, United States and United Kingdom. John C. W. Lim's co-authors include Murray Lumpkin, Silke Vogel, Tomas Salmonson, Carole Longson, Reiner Banken, L G Baird, Janet Woodcock, Finn Børlum Kristensen, Robyn Lim and Sean Tunis and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

John C. W. Lim

18 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. W. Lim Singapore 8 122 68 29 26 22 20 236
Manoela Manova Bulgaria 10 147 1.2× 24 0.4× 26 0.9× 44 1.7× 11 0.5× 53 314
Lada Leyens Netherlands 9 79 0.6× 43 0.6× 10 0.3× 17 0.7× 22 1.0× 19 307
Sue Hill United Kingdom 9 72 0.6× 130 1.9× 42 1.4× 34 1.3× 83 3.8× 21 565
Matthew Herder Canada 11 139 1.1× 93 1.4× 28 1.0× 35 1.3× 61 2.8× 55 346
Jonas Häggström Canada 7 28 0.2× 31 0.5× 19 0.7× 22 0.8× 20 0.9× 8 218
Gregory Powell United States 7 39 0.3× 33 0.5× 25 0.9× 17 0.7× 8 0.4× 11 329
Geoffrey Banda United Kingdom 9 72 0.6× 71 1.0× 13 0.4× 29 1.1× 14 0.6× 25 231
K. Hernández-Villafuerte Germany 6 73 0.6× 23 0.3× 19 0.7× 14 0.5× 10 0.5× 15 255
Ken Getz United States 9 44 0.4× 84 1.2× 27 0.9× 10 0.4× 24 1.1× 20 234
Benjamin Gregory Carlisle Canada 10 178 1.5× 235 3.5× 80 2.8× 34 1.3× 72 3.3× 30 488

Countries citing papers authored by John C. W. Lim

Since Specialization
Citations

This map shows the geographic impact of John C. W. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. W. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. W. Lim more than expected).

Fields of papers citing papers by John C. W. Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. W. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. W. Lim. The network helps show where John C. W. Lim may publish in the future.

Co-authorship network of co-authors of John C. W. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of John C. W. Lim. A scholar is included among the top collaborators of John C. W. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. W. Lim. John C. W. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wouters, Olivier J., et al.. (2025). Regional cooperation on pandemic preparedness and vaccine equity from an economic, regulatory and legal perspective. Vaccine. 53. 127107–127107. 1 indexed citations
3.
Ghosh, Chiradeep, et al.. (2025). Non-clinical direct-to-consumer genetic testing: a scoping review of regulatory frameworks and issues. Health Policy and Technology. 14(6). 101106–101106.
4.
5.
Hatchett, Richard, et al.. (2024). Regulation in the age of calamity: Changing the regulatory paradigm. Clinical and Translational Science. 17(7). e13882–e13882. 3 indexed citations
6.
7.
Teo, Zhen Ling, John C. W. Lim, Carolyn S.P. Lam, et al.. (2023). Artificial intelligence innovation in healthcare: Relevance of reporting guidelines for clinical translation from bench to bedside. Annals of the Academy of Medicine Singapore. 52(4). 199–212. 4 indexed citations
8.
Heaton, Penny M., et al.. (2023). Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective. Clinical Pharmacology & Therapeutics. 114(3). 504–506. 2 indexed citations
9.
Lim, John C. W., et al.. (2023). Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making. Drug Safety. 47(3). 217–225. 2 indexed citations
10.
Crane, Gracy, John C. W. Lim, Churn‐Shiouh Gau, Jipan Xie, & Laura Chu. (2022). The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations. Current Medical Research and Opinion. 38(9). 1543–1551. 7 indexed citations
11.
Wu, Patricia, et al.. (2021). Measuring Progress of Regulatory Convergence and Cooperation Among Asia–Pacific Economic Cooperation (APEC) Member Economies in the Context of the COVID-19 Pandemic. Therapeutic Innovation & Regulatory Science. 55(4). 786–798. 9 indexed citations
12.
Vogel, Silke, et al.. (2021). Science, Innovation, and Society in the Age of Pandemics: Reflections From the Inaugural Sir Alasdair Breckenridge Lecture. Clinical Pharmacology & Therapeutics. 111(3). 548–550. 1 indexed citations
13.
14.
Lumpkin, Murray & John C. W. Lim. (2020). Pandemic Best Regulatory Practices: An Urgent Need in the COVID‐19 Pandemic. Clinical Pharmacology & Therapeutics. 108(4). 703–705. 11 indexed citations
15.
Lim, John C. W., et al.. (2020). Towards health market systems changes for migrant workers based on the COVID-19 experience in Singapore. BMJ Global Health. 5(9). e003054–e003054. 13 indexed citations
16.
Lumpkin, Murray, et al.. (2020). The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics. Clinical and Translational Science. 14(3). 777–780. 6 indexed citations
17.
Lim, John C. W.. (2018). Strengthening Health Products Regulatory Systems to Enhance Access to Quality Health Products in the Asia-Pacific. Therapeutic Innovation & Regulatory Science. 52(6). 751–754. 6 indexed citations
18.
Bempong, Daniel K., Joseph B. Babigumira, Shabir Banoo, et al.. (2018). Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems. Globalization and Health. 14(1). 102–102. 72 indexed citations
19.
20.
Baird, L G, Reiner Banken, Finn Børlum Kristensen, et al.. (2014). Accelerated Access to Innovative Medicines for Patients in Need. Clinical Pharmacology & Therapeutics. 96(5). 559–571. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manoela Manova Breakdown of academic impact, for papers by Lada Leyens Breakdown of academic impact, for papers by Sue Hill Breakdown of academic impact, for papers by Matthew Herder Breakdown of academic impact, for papers by Jonas Häggström Breakdown of academic impact, for papers by Gregory Powell Breakdown of academic impact, for papers by Geoffrey Banda Breakdown of academic impact, for papers by K. Hernández-Villafuerte Breakdown of academic impact, for papers by Ken Getz Breakdown of academic impact, for papers by Benjamin Gregory Carlisle
Rankless by CCL
2026